| Literature DB >> 24946215 |
Ben-Ren Liao1, Hai-Bing He2, Ling-Ling Yang3, Li-Xin Gao3, Liang Chang1, Jie Tang1, Jing-Ya Li4, Jia Li5, Fan Yang6.
Abstract
With the aim of discovering a novel class of non-phosphorus-based fructose-1,6-bisphosphatase (FBPase) inhibitors, a series of 2,5-diphenyl-1,3,4-oxadiazoles were synthesized based on the hit compound (1) resulting from a high-throughput screening (HTS). Structure-activity relationship (SAR) studies led to the identification of several compounds with comparable inhibitory activities to AMP, the natural allosteric inhibitor of FBPase. Notably, compound 22 and 27b, bearing a terminal carboxyl or 1H-tetrazole, demonstrated remarkable inhibition to gluconeogenesis (GNG). In addition, both inhibition and binding mode to the enzyme were investigated by enzymatic kinetics and in silico experiments for representative compounds 16 and 22.Entities:
Keywords: 2,5-Diphenyl-1,3,4-oxadiazoles; Antidiabetic; Diabetes; Fructose-1,6-bisphosphatase (FBPase); Inhibitor
Mesh:
Substances:
Year: 2014 PMID: 24946215 DOI: 10.1016/j.ejmech.2014.06.011
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514